{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:08:17Z","timestamp":1790024897650,"version":"4.0.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National High Level Hospital Clinical Research Funding of China","award":["2022-NHLHCRF-YS-03"],"award-info":[{"award-number":["2022-NHLHCRF-YS-03"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272196"],"award-info":[{"award-number":["82272196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02310-w","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:54:05Z","timestamp":1784357645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SERPINE1 in ARDS: an emerging regulator of inflammation\u2013coagulation\u2013fibrinolysis crosstalk"],"prefix":"10.1007","volume":"75","author":[{"given":"Nan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Tian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1728-3847","authenticated-orcid":false,"given":"Guo-Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"1","key":"2310_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2310_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788\u2013800.","journal-title":"JAMA"},{"issue":"4","key":"2310_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jointm.2025.08.002","volume":"5","author":"R Merola","year":"2025","unstructured":"Merola R, Battaglini D. Redefining ARDS phenotypes: challenges in the precision medicine era. J Intensive Med. 2025;5(4):333\u20135.","journal-title":"J Intensive Med"},{"issue":"1","key":"2310_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13054-025-05291-0","volume":"29","author":"L Al-Husinat","year":"2025","unstructured":"Al-Husinat L, et al. A narrative review on the future of ARDS: evolving definitions pathophysiology and tailored management. Crit Care. 2025;29(1):88.","journal-title":"Crit Care"},{"issue":"1","key":"2310_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-025-02127-9","volume":"10","author":"W Ma","year":"2025","unstructured":"Ma W, et al. Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies. Signal Transduct Target Ther. 2025;10(1):75.","journal-title":"Signal Transduct Target Ther"},{"issue":"10358","key":"2310_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology and phenotypes. Lancet. 2022;400(10358):1145\u201356.","journal-title":"Lancet"},{"issue":"2 Suppl","key":"2310_CR7","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","volume":"38","author":"M Levi","year":"2010","unstructured":"Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 Suppl):S26-34.","journal-title":"Crit Care Med"},{"issue":"9","key":"2310_CR8","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","volume":"118","author":"JH Foley","year":"2016","unstructured":"Foley JH, Conway EM. Cross talk pathways between coagulation and inflammation. Circ Res. 2016;118(9):1392\u2013408.","journal-title":"Circ Res"},{"issue":"6","key":"2310_CR9","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s00134-006-0167-9","volume":"32","author":"RM Determann","year":"2006","unstructured":"Determann RM, et al. Bronchoalveolar levels of plasminogen activator inhibitor-1 and soluble tissue factor are sensitive and specific markers of pulmonary inflammation. Intensive Care Med. 2006;32(6):946\u20137.","journal-title":"Intensive Care Med"},{"issue":"1","key":"2310_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00134-005-2847-2","volume":"32","author":"AA El Solh","year":"2006","unstructured":"El Solh AA, et al. Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitis. Intensive Care Med. 2006;32(1):110\u20135.","journal-title":"Intensive Care Med"},{"issue":"4","key":"2310_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1165\/rcmb.2004-0407OC","volume":"33","author":"I Vad\u00e1sz","year":"2005","unstructured":"Vad\u00e1sz I, et al. Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+-ATPase. Am J Respir Cell Mol Biol. 2005;33(4):343\u201354.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"2310_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00134-009-1690-2","volume":"36","author":"A Sapru","year":"2010","unstructured":"Sapru A, et al. Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. Intensive Care Med. 2010;36(1):157\u201363.","journal-title":"Intensive Care Med"},{"issue":"6","key":"2310_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1164\/rccm.202210-1925ED","volume":"207","author":"AA Komissarov","year":"2023","unstructured":"Komissarov AA, Idell S. PAI-1 drives septation and clinical outcomes in pleural infection. Am J Respir Crit Care Med. 2023;207(6):653\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2310_CR14","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41467-025-56473-x","volume":"16","author":"JTH Lee","year":"2025","unstructured":"Lee JTH, et al. Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19. Nat Commun. 2025;16(1):1979.","journal-title":"Nat Commun"},{"issue":"16","key":"2310_CR15","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1097\/CM9.0000000000002316","volume":"136","author":"S Jiang","year":"2023","unstructured":"Jiang S, et al. PAI-1 genetic polymorphisms influence septic patient\u2019s outcomes by regulating neutrophil activity. Chin Med J (Engl). 2023;136(16):1959\u201366.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2310_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34\u201345.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2310_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","volume":"38","author":"SP Grover","year":"2018","unstructured":"Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of thrombosis. Arterioscler Thromb Vasc Biol. 2018;38(4):709\u201325.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2310_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2310_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Br\u00fchl","year":"2012","unstructured":"von Br\u00fchl ML, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819\u201335.","journal-title":"J Exp Med"},{"issue":"10","key":"2310_CR20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","volume":"129","author":"B McDonald","year":"2017","unstructured":"McDonald B, et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood. 2017;129(10):1357\u201367.","journal-title":"Blood"},{"key":"2310_CR21","doi-asserted-by":"crossref","unstructured":"Singh, A., G. Boden, and A.K. Rao, Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus. Thromb Haemost, 2015. 113(4): p. 750\u20138.","DOI":"10.1160\/TH14-10-0884"},{"key":"2310_CR22","doi-asserted-by":"crossref","unstructured":"Oeth, P., G.C. Parry, and N. Mackman, Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B\/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol, 1997. 17(2) 365\u201374.","DOI":"10.1161\/01.ATV.17.2.365"},{"issue":"6801","key":"2310_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/35025229","volume":"407","author":"SR Coughlin","year":"2000","unstructured":"Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407(6801):258\u201364.","journal-title":"Nature"},{"issue":"5574","key":"2310_CR24","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1126\/science.1071699","volume":"296","author":"M Riewald","year":"2002","unstructured":"Riewald M, et al. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Sci. 2002;296(5574):1880\u20132.","journal-title":"Sci"},{"issue":"46","key":"2310_CR25","doi-asserted-by":"publisher","first-page":"32979","DOI":"10.1074\/jbc.M113.483123","volume":"288","author":"K Mihara","year":"2013","unstructured":"Mihara K, et al. Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1). J Biol Chem. 2013;288(46):32979\u201390.","journal-title":"J Biol Chem"},{"issue":"10","key":"2310_CR26","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/ni.2691","volume":"14","author":"CN Jenne","year":"2013","unstructured":"Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14(10):996\u20131006.","journal-title":"Nat Immunol"},{"issue":"7","key":"2310_CR27","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364(7):656\u201365.","journal-title":"N Engl J Med"},{"issue":"2","key":"2310_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1172\/JCI114217","volume":"84","author":"S Idell","year":"1989","unstructured":"Idell S, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest. 1989;84(2):695\u2013705.","journal-title":"J Clin Invest"},{"issue":"1","key":"2310_CR29","doi-asserted-by":"publisher","first-page":"L20","DOI":"10.1152\/ajplung.00312.2002","volume":"285","author":"P Prabhakaran","year":"2003","unstructured":"Prabhakaran P, et al. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. American J Physiology-Lung Cellular Molecular Physiol. 2003;285(1):L20\u20138.","journal-title":"American J Physiology-Lung Cellular Molecular Physiol"},{"issue":"4 Suppl","key":"2310_CR30","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1097\/01.CCM.0000057846.21303.AB","volume":"31","author":"S Idell","year":"2003","unstructured":"Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med. 2003;31(4 Suppl):S213\u201320.","journal-title":"Crit Care Med"},{"issue":"4","key":"2310_CR31","first-page":"566","volume":"2","author":"S Idell","year":"1994","unstructured":"Idell S. Extravascular coagulation and fibrin deposition in acute lung injury. New Horiz. 1994;2(4):566\u201374.","journal-title":"New Horiz"},{"issue":"23","key":"2310_CR32","first-page":"2526","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526\u201333.","journal-title":"JAMA"},{"issue":"2","key":"2310_CR33","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/cc6846","volume":"12","author":"D McClintock","year":"2008","unstructured":"McClintock D, et al. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care. 2008;12(2):R41.","journal-title":"Crit Care"},{"issue":"6","key":"2310_CR34","first-page":"737","volume":"13","author":"I Krynytska","year":"2021","unstructured":"Krynytska I, et al. COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review). Iran J Microbiol. 2021;13(6):737\u201347.","journal-title":"Iran J Microbiol"},{"issue":"7","key":"2310_CR35","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/jth.14872","volume":"18","author":"CS Whyte","year":"2020","unstructured":"Whyte CS, et al. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. 2020;18(7):1548\u201355.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2310_CR36","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28(5):e72-91.","journal-title":"Cardiovasc Ther"},{"key":"2310_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-94-011-4722-4_26","volume-title":"Laboratory techniques in thrombosis\u2014a manual","author":"PJ Declerck","year":"1999","unstructured":"Declerck PJ. Plasminogen activator inhibitor-1 (PAI-1) antigen. In: Jespersen J, Bertina RM, Haverkate F, editors. Laboratory techniques in thrombosis\u2014a manual. Dordrecht: Springer Netherlands; 1999. p. 239\u201345."},{"issue":"6","key":"2310_CR38","first-page":"969","volume":"100","author":"EK Kruithof","year":"2008","unstructured":"Kruithof EK. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost. 2008;100(6):969\u201375.","journal-title":"Thromb Haemost"},{"key":"2310_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310592","author":"LA Palafox-Mariscal","year":"2023","unstructured":"Palafox-Mariscal LA, et al. Pentoxifylline inhibits TNF-\u03b1\/TGF-\u03b21-induced epithelial-mesenchymal transition via suppressing the NF-\u03baB pathway and SERPINE1 expression in CaSki Cells. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241310592.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2310_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-024-01985-1","volume":"23","author":"D Zhang","year":"2024","unstructured":"Zhang D, et al. Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-\u03baB p65 nuclear translocation. Mol Cancer. 2024;23(1):70.","journal-title":"Mol Cancer"},{"key":"2310_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122893","volume":"314","author":"MH Fan","year":"2025","unstructured":"Fan MH, et al. Exosomes from hypoxic urine-derived stem cells facilitate healing of diabetic wound by targeting SERPINE1 through miR-486-5p. Biomaterials. 2025;314:122893.","journal-title":"Biomaterials"},{"issue":"1","key":"2310_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13046-024-03269-4","volume":"44","author":"Z Ye","year":"2025","unstructured":"Ye Z, et al. Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression. J Exp Clin Cancer Res. 2025;44(1):2.","journal-title":"J Exp Clin Cancer Res"},{"key":"2310_CR43","doi-asserted-by":"crossref","unstructured":"D'Agnillo, F., et al., Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med, 2021. 13(620): p. eabj7790.","DOI":"10.1126\/scitranslmed.abj7790"},{"issue":"23","key":"2310_CR44","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1097\/CM9.0000000000003342","volume":"137","author":"M Wu","year":"2024","unstructured":"Wu M, et al. Effect of endothelial responses on sepsis-associated organ dysfunction. Chin Med J (Engl). 2024;137(23):2782\u201392.","journal-title":"Chin Med J (Engl)"},{"key":"2310_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103038","volume":"70","author":"X Chen","year":"2024","unstructured":"Chen X, et al. Endothelial H(2)S-AMPK dysfunction upregulates the angiocrine factor PAI-1 and contributes to lung fibrosis. Redox Biol. 2024;70:103038.","journal-title":"Redox Biol"},{"issue":"1","key":"2310_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13287-023-03414-4","volume":"14","author":"G Ali","year":"2023","unstructured":"Ali G, et al. PAI-1 regulates AT2-mediated re-alveolarization and ion permeability. Stem Cell Res Ther. 2023;14(1):185.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"2310_CR47","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/acel.12643","volume":"16","author":"C Jiang","year":"2017","unstructured":"Jiang C, et al. Serpine 1 induces alveolar type II cell senescence through activating p53\u2013p21-Rb pathway in fibrotic lung disease. Aging Cell. 2017;16(5):1114\u201324.","journal-title":"Aging Cell"},{"issue":"1","key":"2310_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.advms.2024.01.004","volume":"69","author":"M Li","year":"2024","unstructured":"Li M, et al. Critical roles of PAI-1 in lipopolysaccharide-induced acute lung injury. Adv Med Sci. 2024;69(1):90\u2013102.","journal-title":"Adv Med Sci"},{"issue":"1","key":"2310_CR49","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1038\/s41467-020-17358-3","volume":"11","author":"M Strunz","year":"2020","unstructured":"Strunz M, et al. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis. Nat Commun. 2020;11(1):3559.","journal-title":"Nat Commun"},{"issue":"10","key":"2310_CR50","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1007\/s00204-022-03342-x","volume":"96","author":"S Zeitlmayr","year":"2022","unstructured":"Zeitlmayr S, et al. TRPM7 restrains plasmin activity and promotes transforming growth factor-\u03b21 signaling in primary human lung fibroblasts. Arch Toxicol. 2022;96(10):2767\u201383.","journal-title":"Arch Toxicol"},{"issue":"10","key":"2310_CR51","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1161\/ATVBAHA.117.309794","volume":"37","author":"RA Campbell","year":"2017","unstructured":"Campbell RA, et al. Clots Are Potent Triggers of Inflammatory Cell Gene Expression: indications for timely fibrinolysis. Arterioscler Thromb Vasc Biol. 2017;37(10):1819\u201327.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2310_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.653655","volume":"8","author":"GB Morrow","year":"2021","unstructured":"Morrow GB, Whyte CS, Mutch NJ. A serpin with a finger in many PAIs: PAI-1\u2019s central function in thromboinflammation and cardiovascular disease. Front Cardiovasc Med. 2021;8:653655.","journal-title":"Front Cardiovasc Med"},{"key":"2310_CR53","doi-asserted-by":"publisher","first-page":"1435236","DOI":"10.3389\/fimmu.2024.1435236","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Fibrinogen induces inflammatory responses via the immune activating receptor LILRA2. Front Immunol. 2024;15:1435236.","journal-title":"Front Immunol"},{"issue":"5","key":"2310_CR54","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1160\/TH07-01-0039","volume":"97","author":"T Jensen","year":"2007","unstructured":"Jensen T, et al. Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb Haemost. 2007;97(5):822\u20139.","journal-title":"Thromb Haemost"},{"issue":"5","key":"2310_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10753-007-9035-1","volume":"30","author":"DB Kuhns","year":"2007","unstructured":"Kuhns DB, Priel DA, Gallin JI. Induction of human monocyte interleukin (IL)-8 by fibrinogen through the toll-like receptor pathway. Inflammation. 2007;30(5):178\u201388.","journal-title":"Inflammation"},{"key":"2310_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105516","author":"M Badran","year":"2022","unstructured":"Badran M, Gozal D. PAI-1: a major player in the vascular dysfunction in obstructive sleep Apnea? Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23105516.","journal-title":"Int J Mol Sci"},{"key":"2310_CR57","doi-asserted-by":"crossref","unstructured":"Tang, M.Y., F.A. Gorin, and P.J. Lein, Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease. Ageing Neurodegener Dis, 2022. 2.","DOI":"10.20517\/and.2022.05"},{"issue":"17","key":"2310_CR58","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1182\/blood.2023022257","volume":"144","author":"C Puy","year":"2024","unstructured":"Puy C, et al. Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo. Blood. 2024;144(17):1821\u201333.","journal-title":"Blood"},{"issue":"12","key":"2310_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145684","volume":"10","author":"AE Daniel","year":"2015","unstructured":"Daniel AE, et al. Plasminogen activator inhibitor-1 controls vascular integrity by regulating VE-cadherin trafficking. PLoS ONE. 2015;10(12):e0145684.","journal-title":"PLoS ONE"},{"issue":"3","key":"2310_CR60","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10753-024-02102-6","volume":"48","author":"N Aji","year":"2025","unstructured":"Aji N, et al. PAI-1 Deficiency promotes NET-mediated Pyroptosis and Ferroptosis during pseudomonas Aeruginosa-induced acute lung injury by regulating the PI3K\/MAPK\/AKT Axis. Inflammation. 2025;48(3):1109\u201324.","journal-title":"Inflammation"},{"issue":"1","key":"2310_CR61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s10020-024-00910-y","volume":"30","author":"J Lin","year":"2024","unstructured":"Lin J, et al. Capsaicin mitigates ventilator-induced lung injury by suppressing ferroptosis and maintaining mitochondrial redox homeostasis through SIRT3-dependent mechanisms. Mol Med. 2024;30(1):148.","journal-title":"Mol Med"},{"key":"2310_CR62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.freeradbiomed.2023.06.017","volume":"205","author":"N Li","year":"2023","unstructured":"Li N, et al. PM2.5 contributed to pulmonary epithelial senescence and ferroptosis by regulating USP3-SIRT3-P53 axis. Free Radic Biol Med. 2023;205:291\u2013304.","journal-title":"Free Radic Biol Med"},{"key":"2310_CR63","doi-asserted-by":"crossref","unstructured":"Andr\u00e1s, I.E., et al., Extracellular vesicle-Serpine-1 affects neural progenitor cell mitochondrial functions and synaptic density: modulation by amyloid beta and HIV-1. Res Sq, 2023.","DOI":"10.21203\/rs.3.rs-2551245\/v1"},{"issue":"8","key":"2310_CR64","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41419-022-05168-y","volume":"13","author":"G Catarinella","year":"2022","unstructured":"Catarinella G, et al. SerpinE1 drives a cell-autonomous pathogenic signaling in Hutchinson-Gilford progeria syndrome. Cell Death Dis. 2022;13(8):737.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2310_CR65","doi-asserted-by":"publisher","first-page":"15140","DOI":"10.1038\/s41598-017-15474-7","volume":"7","author":"I Azimi","year":"2017","unstructured":"Azimi I, et al. Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells. Sci Rep. 2017;7(1):15140.","journal-title":"Sci Rep"},{"key":"2310_CR66","doi-asserted-by":"crossref","unstructured":"Ozolina, A., et al., Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study. Frontiers in Medicine, 2016. Volume 3 2016.","DOI":"10.3389\/fmed.2016.00064"},{"issue":"1","key":"2310_CR67","doi-asserted-by":"publisher","first-page":"L20","DOI":"10.1152\/ajplung.00312.2002","volume":"285","author":"P Prabhakaran","year":"2003","unstructured":"Prabhakaran P, et al. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2003;285(1):L20\u20138.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2310_CR68","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3389\/fimmu.2018.01218","volume":"9","author":"TL Tipoe","year":"2018","unstructured":"Tipoe TL, et al. Plasminogen activator inhibitor 1 for predicting sepsis severity and mortality outcomes: a systematic review and meta-analysis. Front Immunol. 2018;9:1218.","journal-title":"Front Immunol"},{"key":"2310_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20064846","author":"E Wo\u017anica-Niesobska","year":"2023","unstructured":"Wo\u017anica-Niesobska E, et al. The role of plasminogen activator inhibitor 1 in predicting sepsis-associated liver dysfunction: an observational study. Int J Environ Res Public Health. 2023. https:\/\/doi.org\/10.3390\/ijerph20064846.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2310_CR70","doi-asserted-by":"publisher","first-page":"28380","DOI":"10.1038\/s41598-025-06517-5","volume":"15","author":"S Fukahori","year":"2025","unstructured":"Fukahori S, et al. Elevated plasma level of PAI-1 is associated with severe COVID-19. Sci Rep. 2025;15(1):28380.","journal-title":"Sci Rep"},{"key":"2310_CR71","doi-asserted-by":"crossref","unstructured":"Yatsenko, T., et al., Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19. Frontiers in Immunology, 2024. Volume 14 2023.","DOI":"10.3389\/fimmu.2023.1299792"},{"issue":"8","key":"2310_CR72","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1538-7836.2006.02031.x","volume":"4","author":"C Roncal","year":"2006","unstructured":"Roncal C, et al. The 4G\/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin. J Thromb Haemost. 2006;4(8):1798\u2013803.","journal-title":"J Thromb Haemost"},{"key":"2310_CR73","doi-asserted-by":"publisher","first-page":"1445294","DOI":"10.3389\/fimmu.2024.1445294","volume":"15","author":"T Yatsenko","year":"2024","unstructured":"Yatsenko T, et al. The influence of 4G\/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction. Front Immunol. 2024;15:1445294.","journal-title":"Front Immunol"},{"key":"2310_CR74","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2147\/JIR.S277373","volume":"13","author":"AA Yousef","year":"2020","unstructured":"Yousef AA, et al. Association of plasminogen activator inhibitor 1 (PAI-1) 4G\/5G polymorphism and susceptibility to sle in egyptian children and adolescents: aMulticenter study. J Inflamm Res. 2020;13:1103\u201311.","journal-title":"J Inflamm Res"},{"issue":"3","key":"2310_CR75","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1161\/ATVBAHA.107.155556","volume":"28","author":"JP Corsetti","year":"2008","unstructured":"Corsetti JP, et al. Plasminogen activator inhibitor-1 polymorphism (4G\/5G) predicts recurrence in nonhyperlipidemic postinfarction patients. Arterioscler Thromb Vasc Biol. 2008;28(3):548\u201354.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2310_CR76","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/cc8992","volume":"14","author":"K Mad\u00e1ch","year":"2010","unstructured":"Mad\u00e1ch K, et al. 4G\/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study. Crit Care. 2010;14(2):R79.","journal-title":"Crit Care"},{"issue":"14","key":"2310_CR77","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1021\/jm049766q","volume":"47","author":"H Elokdah","year":"2004","unstructured":"Elokdah H, et al. Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization. J Med Chem. 2004;47(14):3491\u20134.","journal-title":"J Med Chem"},{"issue":"1","key":"2310_CR78","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0268-9499(97)80009-4","volume":"11","author":"P Charlton","year":"1997","unstructured":"Charlton P, et al. XR5118, a novel modulator of plasminogen activator inhibitor-1 (PAI-1), increases endogenous tPA activity in the rat. Fibrinolysis and Proteolysis. 1997;11(1):51\u20136.","journal-title":"Fibrinolysis and Proteolysis"},{"issue":"52","key":"2310_CR79","doi-asserted-by":"publisher","first-page":"89887","DOI":"10.18632\/oncotarget.20834","volume":"8","author":"E Nakatsuka","year":"2017","unstructured":"Nakatsuka E, et al. Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination. Oncotarget. 2017;8(52):89887\u2013902.","journal-title":"Oncotarget"},{"issue":"3","key":"2310_CR80","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/jth.14716","volume":"18","author":"M Sillen","year":"2020","unstructured":"Sillen M, et al. Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1\/plasminogen activator interaction. J Thromb Haemost. 2020;18(3):681\u201392.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2310_CR81","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/ATVBAHA.107.157479","volume":"28","author":"Y Izuhara","year":"2008","unstructured":"Izuhara Y, et al. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis. Arterioscler Thromb Vasc Biol. 2008;28(4):672\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2310_CR82","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/ATVBAHA.113.301224","volume":"33","author":"A Ichimura","year":"2013","unstructured":"Ichimura A, et al. A small molecule inhibitor to plasminogen activator inhibitor 1 inhibits macrophage migration. Arterioscler Thromb Vasc Biol. 2013;33(5):935\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2310_CR83","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41598-023-50445-1","volume":"14","author":"T Hirai","year":"2024","unstructured":"Hirai T, et al. A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19. Sci Rep. 2024;14(1):165.","journal-title":"Sci Rep"},{"key":"2310_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.622473","volume":"7","author":"M Sillen","year":"2020","unstructured":"Sillen M, Declerck PJ. Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition. Front Cardiovasc Med. 2020;7:622473.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"2310_CR85","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/j.1538-7836.2008.03063.x","volume":"6","author":"JK Hennan","year":"2008","unstructured":"Hennan JK, et al. Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis. J Thromb Haemost. 2008;6(9):1558\u201364.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2310_CR86","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.thromres.2012.06.023","volume":"130","author":"B Van De Craen","year":"2012","unstructured":"Van De Craen B, Declerck PJ, Gils A. The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo. Thromb Res. 2012;130(4):576\u201385.","journal-title":"Thromb Res"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02310-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T08:02:06Z","timestamp":1784361726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02310-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2310"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02310-w","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"179"}}